HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Union animal testing reg

This article was originally published in The Rose Sheet

Executive Summary

Commission Chemicals Policy White Paper is inconsistent with Parliament's position on animal testing in the Seventh Amendment to the cosmetics directive, European Cosmetic, Toiletry and Perfumery Association maintains in an Oct. 15 statement. "The principal of animal testing where indispensable is recognized in the White Paper on Chemicals: continuing to discriminate against the cosmetics industry on this point is not coherent," Colipa says, noting the cosmetics industry uses chemical ingredients. "Furthermore, it means concentrating on only .3% of the problem," Colipa adds. Chemicals Policy proposes safety assessments for roughly 100,000 chemical substances, which could necessitate animal testing, a measure that is banned under the proposed seventh amendment. The White Paper, which was adopted at the EU committee level Oct. 16, is scheduled for debate before full Parliament Nov. 14...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel